István Alpek

Primus Capital Kockázati Tökealap-kezelö Zrt. (Primus Capital) is the venture capital subsidiary of MKB Bank Nyrt. The firm was founded by Zoltán Bruckner in 2003, and is headquartered in Budapest, Hungary. (BSE:MKBBANK).

Primus Capital Kockázati Tökealap-kezelö Zrt. (Primus Capital) is the venture capital subsidiary of MKB Bank Nyrt. The firm was founded by Zoltán Bruckner in 2003, and is headquartered in Budapest, Hungary. (BSE:MKBBANK).

Primus Capital Kockázati Tökealap-kezelö Zrt. (Primus Capital) is the venture capital subsidiary of MKB Bank Nyrt. The firm was founded by Zoltán Bruckner in 2003, and is headquartered in Budapest, Hungary. (BSE:MKBBANK).

BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary.

BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary.

BBS Nanotechnológia Kutatási és Fejlesztési Kft. engages in the development of novel drug delivery platforms. It offers active ingredients and compounds, chemotherapy and contrast agents, biochemical services, analytical measurements, and cell-based technologies. The company was founded by János Borbély on April 5, 2005 and is headquartered in Debrecen, Hungary.